Importantly, HGF expression levels were not affected by Bcr-Abl inhibitor imatinib, hereby establishing that in CML, HGF production is essentially independent from Bcr-Abl [16]. Here, HGF is linked to chronic myelogenous leukemia, BCR-ABL1 positive.